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Abstract 
 
Although it has been demonstrated that human bone marrow stromal cells (hBMSCs) express the 
ubiquitous connexin43 (Cx43) and form functional gap junctions, their role in the early 
differentiation of hBMSCs into osteoblasts remains poorly documented. Using in vitro assays, we 
show that Cx43 expression and gap junctional intercellular communication (GJIC) are increased 
during the differentiation of hBMSCs into osteoblasts, both at the protein and mRNA levels. Two 
independent procedures to reduce GJIC, a pharmacological approach with GJIC inhibitors (18α-
glycyrrhetinic acid and Gap27 peptide) and a molecular approach using small interfering RNA 
against Cx43, demonstrated that the presence of Cx43 and functional junctional channels are 
essential to the ability of hBMSCs to differentiate into osteoblasts in vitro. In addition, a reduced 
GJIC decreases the expression of Runx2, the major transcription factor implicated in the control of 
osteoblast commitment and early differentiation of hBMSCs into osteoblasts, suggesting that GJIC 
mediated by Cx43 is implicated in this process. Together our results demonstrate that GJIC 
mediated by the Cx43 channels plays a central role throughout the differentiation of hBMSC into 
osteoblasts, from the early stages to the process of mineralization.	
 
Introduction 
 
Bone formation is a regulated process that takes place during embryonic development, growth, 
remodeling and repair. It begins with the commitment of mesenchymal stem cells (MSC) into the 
osteoblastic differentiation program, continues with the early differentiation of stem cells into 
osteoblast progenitors and the subsequent differentiation of these osteoblast progenitors into 
immature osteoblasts, and finally the late differentiation of these immature osteoblast into mature 
osteoblasts (Augello 2010; Vaananen 2005; Neve et al., 2011). These MSC, located mainly in the 
bone marrow stroma, can also differentiate into other mesenchymal cell lineages such as 
fibroblasts, chondrocytes and bone marrow stromal cells including adipocytes, depending on the 
activated signaling transcription pathways (Friedenstein et al., 1987; Owen 1988; Marie 2008). At 
the end of the osteogenic differentiation process, mature osteoblasts produce many markers such 
as alkaline phosphatase (ALP), collagen type I (COL1), bone sialoprotein (BSP), osteopontin and 
osteocalcin (OCN) (Wennberg et al., 2000). This process results in the formation of an extracellular 
organic matrix which will be mineralized.	
Connexins, the structural proteins of gap junctions, are a family of transmembrane proteins that 
oligomerize into hemichannels containing six connexin subunits (Sosinsky 2005). Upon reaching 
the cell surface, two hemichannels pair to complete an intercellular gap junction channel, which 
directly links the cytoplasm of neighboring cells and mediates the exchange of low-molecular-mass 
molecules (<1000 Da), including cAMP, inositol trisphosphate, and Ca
2+ 
(Sohl and Willecke, 2004; 
Nielsen et al., 2012).  
Multiple lines of evidence have established that Cx43, the most abundant connexin in bone 
cells, and subsequent intercellular channels play a major role in skeletal development and for the 
function of osteoblasts (Stains and Civitelli 2016; Plotkin and Stains, 2015). Cx43 gene mutations 
have thus been directly associated with abnormalities of skeletal development observed for 
exemple in oculodentodigital and cranometaphysal dysplasias (Paznekas et al., 2003; Laird, 2014). 
Specifically, it has been demonstrated that Cx43 expression is required for osteoblastic gene 
expression and function in primary and cultured osteoblasts (Lecanda et al., 1998; Lecanda et al., 
2000). For exemple, it has been shown that gap junctional communication is required for the 
maturation process of osteoblastic cells in culture and for the stimulation of osteoblast 
mineralization in response to parathyroid hormone (Schiller et al., 1992; Schiller et al., 2001a; 
Schiller et al., 2001b). In addition, in vivo experiments using either Cx43
-/-
 or Cx43
fl/-
;Col1a.1-2.3 
kb-Cre mice have demonstrated that Cx43 play a crucial role in osteoblastic differentiation and 
function (Plotkin and Stains, 2015).	
However, although it was shown that human MSC (hMSC) express Cx40, Cx43 and Cx45 
(Valiunas et al., 2004, Talbot et al., 2013), and form functional gap junctions, the role of connexins 
in the in vitro differentiation of human MSCs into osteoblast progenitors remains poorly 
documented. In this context, the aim of the present work was to determine the specific role of Cx43 
in the early differentiation of hMSCs into osteoblasts and throughout the process of osteoblast 
differentiation by using small interfering RNA against Cx43 as well as via a pharmacological 
approach with GJIC inhibitors (18α-glycyrrhetinic acid and Gap27 peptide). 
Materials and methods 
 
Ethics statement 
Bone marrow aspirates were obtained from healthy volunteers (age=46±12; range=36-67) during 
orthopaedic surgical procedures after exposure of the iliac crest in the orthopaedic department of 
the University Hospital of Tours (France). The written consent of informed patients was obtained 
for the use of tissue samples for anonymized research, in accordance with French law (Art. L. 
1245-2 du code de la sant publique, Loi n¡ 2004-800 du 6 aot 2004 Journal Officiel du 7 aot 
2004). The donors had no significant medical history. The study followed the ethical guidelines of 
the University Hospital of Tours and was approved by the ethics committee "Comite de protection 
des personnes" (Tours - Region Centre Ouest). 
 
Cell culture  
Human bone marrow stromal cells (hBMSCs) were isolated by Ficoll density gradient separation as 
previously described (Chang et al., 2009). Non-adherent cells were removed by replacing the 
culture medium and hBMSCs were then cultured in medium composed of Dulbecco's Modified 
Eagle Medium (Lonza, Belgium), 10% fetal bovine serum (Hyclone Perbio, France) with 1 ng/ml 
basic fibroblast growth factor (bFGF; R&D systems, UK). Adherent cells were characterized by flow 
cytometry (CD45
-
, CD34
-
, CD105
+
, CD73
+
, CD90
+
 and
 
CD146
+
, purity ≥ 99%) prior to further 
experiments. The expression of each marker was not changed in the presence of bFGF. 
 
Osteoblast differentiation  
hBMSCs were seeded at 1x10
4 
cells/cm
2 
in 24-well plates in culture medium without bFGF. After 3 
days, when the cells were confluent, the medium was replaced by fresh medium supplemented 
with vitamin D3 (10
-8 
M; Hoffmann-La Roche, Switzerland) and dexamethasone (10
-8 
M; Sigma, 
France), referred to as "osteogenic medium" in the text. Three days later, ascorbic acid (50 µg/ml; 
Sigma) and β-glycerophosphate (10
-7 
M; Sigma) was added to allow mineralization. Alizarin red 
staining was used to detect the mineralized nodules formed, as previously described (Chipoy et al., 
2004). Briefly, around day 15, cells were fixed in ice-cold 70% ethanol for 1h and incubated with 
Alizarin red S (40 mM, pH 7.4; Sigma) for 10 min at room temperature. After washing, images were 
captured using a stereo microscope (Stemi 2000-C; Zeiss, Germany), and mineralized surfaces 
were quantified using the Qwin software (Leica, Germany). This software quantifies the red pixel 
intensity of the whole well surface and expresses these values in arbitrary units. Two gap junction 
inhibitors were used: the Cx43 mimetic peptide Gap27 (250 µM; GeneCust, France) and the 
chemical agent 18α-glycyrrhetinic (50 µM; Sigma). Medium in presence or absence of GJIC 
inhibitors was replaced by fresh medium every 24h. Control cultures were treated with the solvent 
(DMSO, Sigma) only. 
 
Western Blot  
Cells were lysed in a lysis buffer (1% SDS, 10mM Tris pH 7.4, 1 mM Sodium orthovanadate) and 
protein concentration was determined by BCA kit (Sigma). 10 µg of total protein extracts in 
Laemmli buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.001% 
bromophenol blue) were separated by SDS-polyacrylamide gel electrophoresis, and transferred to 
Immobilon-P membranes (Millipore, France). Membranes were immunoblotted with mouse 
monoclonal anti-connexin43 (dilution 1/1000, Sigma) or mouse monoclonal anti-GAPDH (dilution 
1/2000, Abcam, France). Antibody binding was visualized with the enhanced chemiluminescence 
system (SuperSignal West Pico Chemiluminescent Substrate, ThermoSientific, France). For 
quantification, luminescence was detected with a Charge Couple Device (CCD) camera and 
analyzed using the GeneTools program (Syngene, UK). 
 
Real-time polymerase chain reaction 
Total RNA was extracted using NucleoSpin
¨
RNAII (Macherey Nagel, France). 1 µg of total RNA 
was used for first strand cDNA synthesis using ThermoScript RT-PCR System (Invitrogen, France). 
DNase I treatment (25 units, 10 min) of total RNA was performed to eliminate genomic 
contamination. Real-time PCR was performed with a Chromo4 instrument (Biorad, France) using 
SYBR Green Supermix reagents (Biorad). Primer sequences are provided in Table 1. Calibration 
curves with different amounts of cDNA were used to validate the primers according the MIQE 
guidelines (Bustin et al., 2009). Cyc1 (cytochrome c-1) and Hprt 1 (Hypoxanthine guanine 
phosphoribosyl transferase 1) were used as internal controls to normalize the data to determine the 
relative expression of the target genes using the 2
-ΔΔCt
 method. 
 Plasmid constructs, transient cell transfections and reporter assays 
The Cx43 promoter/gene reporter construct -2400Cx43-lux was a gift from GI Fishman, The Leon 
H. Charney Division of Cardiology, New York University School of Medicine, New York, NY and 
has been described previously (De Leon et al., 1994). Transient cell transfections were performed 
with jetPEI
TM
 (Polyplus-transfection, France). The phRLMLP-Renilla luciferase expression vector 
was cotransfected in every experiment to monitor transfection efficiencies. Luciferase activity was 
determined with the Dual-Luciferase reporter assay system (Promega, France).  
 
RNA interference 
Modified hBMSCs cells were obtained by lentiviral cell transduction as previously described 
(Trichet et al., 2006). Oligonucleotides were designed and cloned into pSUPER to produce the 
short hairpin RNA shRNACx43 directed against the human Cx43 gene. The targeted sequence 
was TGCTGCGAACCTACATCAT. The cloned oligonucleotides were controlled by sequencing 
(Genome Express) before subcloning them with the upstream H1 promoter into the vector pFG12. 
As a control, a vector pFG12 was developed to produce shRNAs targeting the LacZ gene. The 
resulting constructs were used for lentivirus production following the protocols provided with the 
ViraPower Lentiviral Expression System (Invitrogen) to transduce hBMSCs.  
 
Parachute assay 
Gap junctional intercellular communication (GJIC) was determined by ÒparachuteÓ assay, as 
previously described (Ziambaras et al., 1998, Talbot et al., 2013; Tellez-Gabriel et al., 2017). Cell 
cultures were divided into ÒacceptorÓ and ÒdonorÓ cell groups. Adherent acceptor cells were loaded 
with DiI (Sigma; 5 µM), a nontransferable membrane dye, for 1h, and confluent donor cells were 
dyed with calcein-acetoxymethylester (calcein-AM; Sigma; 1 µM), a gap junction permeant dye, 
for 45 min. After loading, cells were washed in PBS to remove the excess dye. Then, the calcein-
AM-dyed cells were trypsinized and parachuted on the DiI-dyed acceptor cell layer at a cell ratio 
of 1:10 and incubated at 37¡C for 2h to allow calcein transfer via gap junctions. Dye coupling was 
analyzed using a FACS FC500 cytometer (Beckman Coulter). For the analysis of results, gates 
were established on the day of each experiment using non-dyed cells, cells dyed with calcein-AM, 
and cells dyed with DiI.  
 
Cell proliferation assay (test XTT) 
Cell viability was determined using a 2,3- bis(2 methoxy-4 nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide (XTT) reagent assay kit (Roche Molecular Biomedicals, Germany). Two thousand 
cells per well were plated into 96-well plates. At confluence, cells were cultured for 17 days in 
culture medium in the presence or absence of GJIC inhibitors. 
 
 
Statistical analysis  
Analyses were performed using GraphPad Prism 6.0 software (GraphPad Software). The 
unpaired t-test was used for the comparison of two conditions. An ANOVA test was used for the 
multi-group comparisons of more than two samples. A two-way ANOVA test was used for multi-
group comparisons of data that compare two variables. The results are given as mean ± SD. 
Results with p<0.05 were considered significant. 
Results 
 
Increased production of Cx43 during the differentiation of hBMSCs into osteoblasts in 
vitro 
We first analyzed the in vitro differentiation of hBMSC into osteoblasts under our experimental 
conditions (see materials and methods). As shown in Figure 1A, incubation of hBMSCs in 
monolayer cultures with osteogenic medium over 2 weeks resulted in osteoblastic differentiation 
process as demonstrated by  a marked increase in mineral deposition revealed by Alizarin red 
staining. Concurrently, there was an increase in the expression of genes associated with 
osteoblast differentiation (Figure 1B). The expression of Runx2, the main transcriptional factor 
involved in the osteoblast commitment and the early differentiation of hBMSCs into osteoblast 
progenitors (Marie, 2008), was increased quickly after stimulation of hBMSCs with osteogenic 
medium. Indeed, quantitative real-time PCR demonstrated that Runx2 mRNA levels increased 
from day 1 until day 3 and then decreased. Quantitative real-time PCR demonstrated that the 
levels of transcripts encoding Alkaline Phosphatase	 (ALP), a gene associated with the 
differentiation of osteoblast progenitors into immature osteoblasts, increased from day 3 to day 7, 
and then slowly returned to basal level. The transcript levels of Bone Sialoprotein (BSP) and 
Osteocalcin (OCN), two genes associated with the late differentiation of immature osteoblasts into 
mature osteoblasts, gradually increased starting at day 13 and day 7, respectively, until the end of 
the experiment. As expected, the expression of Sox9, a transcription factor implicated in 
chondrocyte differentiation was not modified after stimulation of hBMSCs with osteogenic medium 
(data not shown).  
We secondly analyzed the production of Cx43 during hBMSC differentiation into osteoblasts 
under our experimental conditions. Interestingly, Western-Blot analysis showed an increase in 
Cx43 protein level after treatment of hBMSCs with osteogenic medium for 9 days, which remained 
stable until day 15 (Figure 2A). To determine whether the induction of Cx43 production during 
hBMSC differentiation occurred via modulation of the corresponding gene, the Cx43 mRNA 
steady-state levels following treatment with osteogenic medium were measured by real-time PCR. 
As shown in Figure 2B, induction of Cx43 mRNA was observed in response to osteogenic 
medium after 9 days of treatment, and Cx43 levels remained elevated until day 17. By contrast, 
no change in the expression of Cx45 was observed during this process of hBMSC differentiation 
(Figure 2B). Although the presence of Cx40 has been demonstrated in hMSC (Valiunas et al., 
2004), its expression level remains very low (under the limit of capacity of detection by PCR in our 
experimental conditions) throughout the differentiation process (data not shown). To further 
explore whether the effect of osteogenic medium on Cx43 gene expression takes place at the 
transcriptional level, transient cell transfections were performed with the Cx43 promoter/gene 
reporter construct -2400Cx43-lux. As shown in Figure 2C, osteogenic medium induced a 6.5-fold 
transactivation of the Cx43 promoter in hBMSCs. To determine whether the increase in Cx43 
gene expression in hBMSCs during osteogenic differentiation is associated with gap junctional 
intercellular communication changes, GJIC was analyzed by FACS using the parachute assay. 
GJIC was significantly enhanced (26-fold increase) after 17 days of incubation of hBMSCs with 
osteogenic medium (Figure 2D). 
Together, these results demonstrated an increase in Cx43 production and subsequent cell-cell 
communication during the differentiation of hBMSCs into osteoblasts. 
 
Small interfering RNA against Cx43 and treatment with 18α-glycyrrhetinic acid or Gap27 
peptide efficiently reduce GJIC between hBMSCs 
To investigate the role of Cx43 and GJIC during the early differentiation of hBMSCs into 
osteoblast progenitors and throughout the process of hBMSC differentiation into mature 
osteoblasts, Cx43 was stably knocked down in hBMSCs by transduction with a lentiviral vector or 
the cells were treated with the GJIC inhibitor 18α-glycyrrhetinic acid or with the peptide Gap27.  
As shown in Figure 3A, shCx43 cells were characterized by a significant (70%) reduction in 
Cx43 mRNA levels compared to shLacZ or parental cells used as control. This decrease was 
confirmed at the protein level (Figure 3B). The knocked down of Cx43 does not change the Cx45 
gene expression in hBMSCs (Figure 3A). In addition, GJIC analysis using the parachute assay 
demonstrated that GJIC was significantly decreased (by 50%) in shCx43 cells compared to 
shLacZ cells or parental hBMSCs (Figure 3C). Of note, the Cx43 knock-down does not affected 
the proliferation rate of the cells (data not shown). As shown in Figure 3D both, 18α-glycyrrhetinic 
(50 µM) acid and Gap27 peptide (250 µM) significantly reduce GJIC between hBMSCs by 
respectively 70% and 60% after 24h incubation of the cells. Of note, in the experimental 
conditions used, the viability of cells was not affected in the presence of 18α-glycyrrhetinic acid or 
Gap27  peptide throughout the experiment (Figure 3E). 
Together these results demonstrated that small interfering RNA against Cx43 or treatment with 
two GJIC inhibitors efficiently reduce GJIC between hBMSCs 
 
Cx43 knocked down blocks the differentiation of hBMSCs into osteoblasts 
We next investigated the effect of the Cx43 knocked down on the osteogenic differentiation of 
hBMSCs. As shown in Figure 4A, an early decrease in Runx2 expression was observed in 
shCx43 cells in response to osteogenic medium compared to that measured in shLacZ cells or in 
parental cells. Indeed, Runx2 mRNA steady-state levels were increased by approximately 3-fold 
in parental and shLacZ cells after treatment of hBMSCs with osteogenic medium for 1 day, but 
only by 1.7-fold in shCx43 cells. Furthermore, a significant decrease in ALP, BSP and OCN 
expression levels was observed in shCx43 cells in response to osteogenic medium compared to 
those measured in shLacZ or in parental cells. ALP mRNA steady-state levels were increased by 
approximately 9-fold in parental and shLacZ cells, but only by 2-fold in shCx43 cells after 7 days 
of incubation with osteogenic medium (Figure 4A). OCN and BSP mRNA steady-state levels were 
increased by approximately 180- and 16-fold, respectively, in parental and shLacZ cells, and only 
by 120- and 8-fold in shCx43 cells after treatment of hBMSCs with osteogenic medium for 17 
days (Figure 4A). Interestingly, after 17 days of treatment with osteogenic medium, a marked 
decrease (60%) in mineral deposition was measured in shCx43 monolayer cultures compared to 
that measured in shLacZ or in parental cultures (Figure 4B). Finally, the expression level of Cx45 
was evaluated by quantitative real-time PCR throughout the process of differentiation. As shown 
in Figure 4C, the expression level of Cx45 is not modified by the knocked down of Cx43 in 
hBMSC and remains unchanged throughout the process of differentiation. In contrast and as 
expected, the expression level of Cx43 was decreased after hBMSC infection with the shRNA 
against Cx43 and remains very low throughout the process of differentiation.	
Together, these results indicate a crucial role of Cx43 during the early differentiation of 
hBMSCs into osteoblasts and throughout the process of osteoblast differentiation. 
 
 
Treatment with GJIC inhibitors inhibits the differentiation of hBMSCs into osteoblasts 
To investigate the role GJIC, and not only the role of Cx43 expression, during the early 
differentiation of hBMSCs into osteoblast progenitors and throughout the process of hBMSC 
differentiation into mature osteoblasts, the cells were treated with 18α-glycyrrhetinic acid or 
Gap27  peptide.  
As shown in Figure 5A, a significant decrease in Runx2 expression level in response to 
osteogenic medium was observed in the presence of 18α-glycyrrhetinic acid or Gap27 peptide 
compared to hBMSCs cultured without inhibitor. Treatment of hBMSCs with osteogenic medium 
for 1 day induced a 3.6-fold increase in Runx2 mRNA steady-state levels. By contrast, Runx2 
level increased by only 1.4-fold and 1.6-fold in the presence of 18α-glycyrrhetinic acid or Gap27 
 peptide. A significant decrease in ALP, BSP and OCN expression levels in response to 
osteogenic medium was also observed in the presence of 18α-glycyrrhetinic acid or Gap27 
peptide compared to hBMSC controls (Figure 5A). ALP mRNA steady-state levels were increased 
by 8.6-fold in the absence of a GJIC  inhibitor, while treatment with 18α-glycyrrhetinic acid or 
Gap27  peptide induced only a 2.2-fold and 3.2-fold increase in mRNA levels, respectively, after 7 
days of incubation of hBMSCs in osteogenic medium. Treatment of hBMSCs with osteogenic 
medium for 17 days induced an increase in OC and BSP mRNA steady-state levels of 137- and 
10-fold, respectively. By contrast, OCN and BSP levels increased by only 30- and 2.3-fold in the 
presence of 18α-glycyrrhetinic acid, and by 63- and 4.7-fold in the presence of Gap27  peptide. In 
agreement with these data, a significant decrease in mineral deposition was measured in the 
presence of 18α-glycyrrhetinic acid or Gap27 peptide compared to cells cultured in the absence of 
GJIC inhibitors. After 17 days of treatment with osteogenic medium, hBMSCs treated with 18α-
glycyrrhetinic acid or Gap27 peptide showed significantly less Alizarin red S staining (95% and 
60%, respectively) compared to cells cultured without GJIC  inhibitor (Figure 5B).  
Together, these results indicate an important role GJIC during the early differentiation of 
hBMSCs into osteoblasts and throughout the process of osteoblast differentiation. 
Discussion 
 
Previous in vitro studies have demonstrated the importance of Cx43 in osteoblast function and 
during the late stages of osteoblast differentiation specifically during the differentiation of 
immature osteoblasts into mature osteoblasts able to mineralize (Plotkin anf Bellido, 2013; Stains 
and Civitelli, 2016). In vivo experiments using either Cx43
-/-
 or Cx43
fl/-
;Col1a.1-2.3 kb-Cre mice 
have demonstrated that Cx43 play a crucial role in osteoblastic differentiation (Plotkin and Stains, 
2015). However, the role of Cx43 in the early differentiation of hBMSCs into osteoblasts in vitro 
remains poorly documented.  
In the present study, we first demonstrate that Cx43 expression is increased at the 
transcriptional level during the late differentiation of hBMSCs into mature osteoblasts. Many 
transcription factors control osteoblastogenesis. Among them, activator protein-1 (AP-1), a 
dimeric transcription factor formed by Fos (c-Fos, Fra-1, Fra-2, FosB) and Jun proteins (c-Jun, 
JunB, JunD) is required for bone formation and remodeling (Eferl and Wagner 2003). For 
example, most Fos proteins are implicated in the proliferation and differentiation of osteoblasts 
(Grigoriadis et al., 1993). Interestingly, one AP-1-binding site has been identified in the human 
Cx43 proximal promoter P1 (approximately 150 nucleotides up- and downstream of the 
transcription initiation site), suggesting that this AP-1 response element could be involved in the 
increased expression of Cx43 during hBMSC differentiation into osteoblasts.  
Additionally, we demonstrate that Cx43 and subsequent GJIC play an important role throughout 
the differentiation of hBMSCs into osteoblasts from the early stages to the process of 
mineralization. It is well recognized that gap junctional communication plays an important role in 
the control of differentiation into different cell types and tissues (Duval et al., 2002). Specifically, it 
has been shown that Cx43 and GJIC are crucial in the regulation of self-renewal and maintenance 
of pluripotency in embryonic stem cells (Todorova et al., 2008). With regard to hBMSC 
differentiation, osteoblastogenesis may be schematically defined by three phases (Marie,  2008): 1) 
the osteoblast commitment of hBMSCs and the early differentiation of hBMSCs into osteoblast 
progenitors, 2) the differentiation of these osteoblast progenitors into immature osteoblasts, and 3) 
the differentiation of immature osteoblasts into mature osteoblasts able to mineralize. All these 
three phases are characterized by sequentially expressed genes. The first stage is characterized 
by the expression of Runx2, the earliest and the most specific transcription factor of mesenchymal 
stem cell commitment toward osteoblastic lineage (Wagner and Karsenty, 2001). Runx2 is indeed 
expressed in all mesenchymal condensations before osteoblast differentiation during early murine 
skeleton development at E10.5-E12.5 (Ducy et al., 1997). Our in vitro results showed that Runx2 is 
induced very early, 1 day after stimulation of hBMSCs with osteogenic medium. This early increase 
in Runx2 expression precedes the increased expression of ALP (expression peak at day 7), a gene 
specific to the differentiation of osteoblast progenitors into immature osteoblasts (the second stage 
of the differentiation process). In this work, we specifically demonstrated that the early increase in 
Runx2 expression observed after stimulation of hBMSCs with differentiation medium is inhibited 
both by the use of an shRNA against Cx43 or by GJIC inhibitors, suggesting that Cx43 as well as 
GJIC play a role during the commitment of hBMSCs toward osteoblastic lineage or at least during 
the early stages of hBMSC differentiation into osteoblast progenitors. In addition, using hBMSCs 
rather than osteoblast progenitors used in previous studies, our results also demonstrated that 
Cx43 plays a central role during the differentiation of osteoblast progenitors into immature 
osteoblasts and later during the differentiation of these immature osteoblasts into mature 
osteoblasts. 	
Regarding the convergence of Cx43 and Runx2 expressions, it has been previously 
demonstrated that the overexpression or knockdown of Cx43 is able to regulate the expression 
and/or the transcriptional activity of Runx2 in several cells such as MC3T3-E1, mouse calvaria 
osteoblastic, human fetal osteoblastic or longitudinal ligament cells (Stains et al., 2003; Li et al., 
2006; Thi et al., 2010; Niger et al., 2011; Niger et al., 2012; Yang et al., 2016). The studies on the 
molecular mechanism underlying this process have identified two effectors, the extracellular signal-
regulated kinase (ERK) and the protein kinase C delta (PKC), responsible for Cx43-regulation of 
Runx2 expression and/or Runx2 transcriptional activity (Lima et al., 2009; Niger et al., 2013; Niger 
et al., 2012; Li et al., 2015; Tu et al., 2016). 
Gap junctions can mediate the passage of nucleotides, amino acids, ions and second 
messengers between coupled cells allowing ionic and metabolic signaling communication (Harris, 
2007). Among these messengers able to cross through gap junctional channels, there is evidence 
that the spatial and temporal patterns of calcium are crucial in the regulation of the differentiation 
process. Both the stable increase in Ca2+ intracellular concentration ([Ca2+]), and the oscillations 
of [Ca2+] are a mode of signaling in both excitable and non-excitable cells. In bone marrow-derived 
stem cells, spontaneous [Ca2+] oscillations were shown to depend on Inositol P3-mediated Ca2+ 
release followed by Ca2+ influx from the extracellular compartment (Kawano et al., 2002). In this 
context, it has been shown that [Ca2+] oscillations can be regulated by intercellular coupling 
through gap junctions (Dupont et al., 2007). We can thus hypothesize that Cx43-mediated gap 
junctional intercellular communication drives the differentiation of hBMSCs into osteoblasts via its 
ability to propagate [Ca2+] oscillations. However, future studies are required to establish the nature 
of the signals, Ca2+ or others, which drive the hBMSC differentiation process.  
Legends of Figures 
 
Figure 1: In vitro differentiation of hBMSCs toward osteoblasts  
hBMSCs were cultured in the presence or absence of osteogenic medium up to 17 days. (A) At 
each time point, cultures were fixed and stained with Alizarin red S. Results show one 
representative experiment of three independent experiments. (B) Runx2, Alkaline Phosphatase 
(ALP), Bone Sialoprotein (BSP) and Osteocalcin (OCN) mRNA steady-state levels were 
determined by quantitative RT-PCR, and are expressed relative to the control culture in absence of 
osteogenic medium. Bars indicate mean ± SD of three independent experiments performed in 
duplicate. 
 
Figure 2: Increase of Cx43 production during the differentiation of hBMSCs into osteoblasts. 
hBMSCs were cultured in the presence or absence of osteogenic medium (Diff) up to 17 days. (A) 
Cx43 production was detected by Western Blot analysis. Result shown is representative of three 
independent experiments. (B) Cx43 and Cx45 mRNA steady-state levels were determined by 
quantitative RT-PCR, and expressed relative to the control culture in absence of osteogenic 
medium. Bars indicate mean ± SD of three independent experiments performed in duplicate. (C) 
hBMSC cells were incubated in the presence or absence of osteogenic medium for 9 days. After 
incubation, cell cultures were transfected with the -2400Cx43-lux construct, and incubation 
continued for another 48h. Bars indicate mean ± SD of three independent experiments performed 
in duplicate. (***p<0.01) (D) FACS analysis of calcein transfer in hBMSCs treated or not with 
osteogenic medium during 17 days. Histogram plots (left panel) represent the mean of 
fluorescence recorded in FL1 channel, which corresponds to calcein-positive cells. Control peak 
corresponds to cells dyed with DiI only, and parachute peak to cells double-labeled. Histograms 
(right panel) indicate mean of the relative transfer-ratio of calcein between cells, which represents a 
direct measure of the degree of dye coupling. Bars indicate mean ± SD of three independent 
experiments performed in duplicate. (***p<0.01) 
 
Figure 3: Small interfering RNA against Cx43 and GJIC inhibitors efficiency block GJIC in 
hBMSCs  
(A) Cx43 and Cx45 mRNA steady-state levels were determined by quantitative RT-PCR in parental 
(P), shLacZ and shCx43 cells as indicated. Bars indicate mean ± SD of three independent 
experiments performed in duplicate. (**p<0.05) (B) Cx43 production was detected by Western Blot 
analysis in parental, shLacZ and shCx43 cells as indicated. Result shown is representative of three 
independent experiments. (C) FACS analysis of calcein transfer in parental, shLacZ and shCx43 
hBMSCs treated or not with osteogenic medium (Diff) for 17 days. Bars indicate mean ± SD of 
three independent experiments performed in duplicate. (***p<0.01). (D) FACS analysis of calcein 
transfer in hBMSCs treated or not with 18α-glycyrrhetinic acid (50 µM) or Gap27 peptide (250 µM) 
for 24h. Bars indicate mean ± SD of three independent experiments performed in duplicate. 
(***p<0.01). (E) hBMSCs viability, treated or not with 18α-glycyrrhetinic acid (50 µM) or Gap27 
peptide (250 µM), was determined using a 2,3- bis(2 methoxy-4 nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide (XTT) reagent assay kit. Bars indicate mean ± SD of three independent 
experiments performed in duplicate. 
 
Figure 4: Small interfering RNA against Cx43 inhibits the differentiation of hBMSCs into 
osteoblasts. 
(A) Parental, shLacZ and shCx43 cells were cultured in the presence or absence of osteogenic 
medium. The expression of Runx2 was determined by quantitative RT-PCR after incubation of 
hBMSCs with osteogenic medium for 1 day. The expression of ALP was determined by quantitative 
RT-PCR after incubation of hBMSCs with osteogenic medium for 7 days. The expression of BSP 
and OCN mRNA steady-state levels were measured by quantitative RT-PCR after incubation of 
hBMSCs with osteogenic medium for 17 day. Bars indicate mean ± SD of three independent 
experiments performed in duplicate. (**p<0.05, ***p<0.01). (B) Parental, shLacZ and shCx43 
hBMSCs were cultured in the presence or absence of osteogenic medium. 17 days after induction 
of osteogenesis, cultures were fixed and stained with Alizarin red S. Results show one 
representative experiment of three independent experiments. (C) Parental, shLacZ and shCx43 
cells were cultured in the presence or absence of osteogenic medium. The expression of Cx43 and 
Cx45 were determined by quantitative RT-PCR throughout the differentiation process. Results 
indicate mean ± SD of three independent experiments performed in duplicate. 
 
Figure 5: GJIC inhibitors reduce the differentiation of hBMSCs into osteoblasts. 
(A) hBMSCs were cultured in the presence of GJIC inhibitors (α-glycyrrhetinic acid or Gap27) as 
indicated. The expression of Runx2 was determined by quantitative RT-PCR after treatment with 
osteogenic medium for 1 day. The expression of ALP was determined by quantitative RT-PCR 
after treatment with osteogenic medium for 7 days. 17 days after treatment of the cells with 
osteogenic medium (Diff), BSP and OCN mRNA steady-state levels were determined by 
quantitative RT-PCR. Bars indicate mean ± SD of three independent experiments performed in 
duplicate. (**p<0.05; ***p<0.01). (B) Cultures were fixed and stained with Alizarin red S 17 days 
after induction of osteogenesis in the presence or absence of 18α-glycyrrhetinic acid (50 µM) or 
Gap27 (250 µM). Results show one representative experiment of three independent experiments.  
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Table 1. Primer sequence for quantitative RT-PCR 
Gene Gene (full name) Accession number Forward primer Reverse primer 
Cx43 Connexin43 NM_000165.3 gcctgaacttgccttttcat ctccagtcacccatgttgc 
OC Osteocalcin NM_199173.2  ggcgctacctgtatcaatgg  tcagccaactcgtcacagtc  
BSP Bone sialoprotein NM_004967  cgaatacacgggcgtcaatg gtagctgtactcatcttcataggc 
ALP Alkaline phosphatase NM_000478.3  aacaccacccaggggaac ggtcacaatgcccacagatt 
Runx2 Runt-related transcription factor 2 NM_004348.3  gcctaggcgcatttcaga gctcttcttactgagagtggaagg 
 
SOX9 SRY (sex determining region Y)-
box9 
NM_000346.3 gtacccgcacttgcacaac 
 
tcgctctcgttcagaagtctc 
 
Cx45 Connexin 45 NM_005497.3 tgggtaaccgaagttctggaca gaacagtgagccagatcttccc 
Hprt 1 Hypoxanthine guanine 
phosphoribosyl transferase 1 
NM_000194.1 tgaccttgatttattttgcatacc cgagcaagacgttcagtcct 
Cyc1 Cytochrome c-1 NM_001916 gcatggtggtgaggactacg ggccaggaaagtaggggttg 
 
!
